Manipulation of the induction of adjuvant arthritis in Sprague-Dawley rats

Inflammation Research

Volumn 55, Issue 9, 2006, Pages 368-377

  Cai, X ^a   Wong, Y F ^a   Zhou, H ^a   Liu, Q ^a   Xie, Y ^a   Jiang, Z H ^a   Bian, Z X ^a   Xu, H X ^b   Liu, L ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adjuvant induced arthritis; Mycobacterium tuberculosis; Pro inflammatory cytokines; Sprague Dawley rats

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARTICLE SIZE; RADIOLOGY; RAT; RAT STRAIN; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MYCOBACTERIUM TUBERCULOSIS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TARSAL JOINTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35648967927     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6026-x     Document Type: Article

References (34)

1. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 1956; 91: 95-101.
2. Pearson CM. Experimental joint disease observations on adjuvant-induced arthritis. J Chronic Dis 1963; 16: 863-74.
3. Billingham ME. Models of arthritis and the search for anti-arthritic drugs. Pharmacol Ther 1983; 21: 389-428.
4. van Eden W, Wagenaar-Hilbers JPA, Wauben MHM. Animal models for autoimmune and inflammatory disease: adjuvant arthritis in the rat. In: Colagin JE, editor. Current Protocols in Immunology. New York: John Wiley, 1994: Unit 15.4: 1-11.
5. Glenn EM, Gray J. Adjuvant-induced polyarthritis in rats: biologic and histologic background. Am J Vet Res 1965; 26: 1180-94.
6. Griffiths MM. Immunogenetics of collagen-induced arthritis in rats. Int Rev Immunol 1988; 4: 1-15.
7. Swingle KF, Jaques LW, Kvam DC. Differences in the severity of adjuvant arthritis in four strains of rats. Proc Soc Exp Biol Med 1969; 132: 608-12.
8. Rosenthale ME. A comparative study of the Lewis and Sprague Dawley rat in adjuvant arthritis. Arch Int Pharmacodyn Ther 1970; 188: 14-22.
9. Banik RK, Kasai M, Mizumura K. Reexamination of the difference in susceptibility to adjuvant-induced arthritis among LEW/Crj, Slc/Wistar/ST and Slc/SD rats. Exp Anim 2002; 51: 197-201.
10. Battisto JR, Smith RN, Beckman K, Sternlicht M, Welles WL. Susceptibility to adjuvant arthritis in DA and F344 rats: a dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum 1982; 25: 1194-200.
11. Kohashi O, Kuwata J, Umehara K, Uemura F, Takahasi T, Ozawa A. Susceptibility to adjuvant-induced arthritis among germ-free, specific pathogen-free, and conventional rats. Infect Immun 1979; 26: 791-4.
12. Best R, Christian R, Lewis DA. Effect of particle size of dried mycobacteria on adjuvant induced arthritis in the rat. Agents Actions 1984; 14: 265-8.
13. International Council for Standardization in Haematology (Expert Panel on Blood Rheology). ICSH recommendations for measurement of erythrocyte sedimentation rate. J Clin Pathol 1993; 46: 198-203.
14. Esser RE, Hildebrand AR, Angelo RA, Watts LM, Murphey MD, Baugh LE. Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. Arthritis Rheum 1995; 38: 129-38.
15. Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH et al. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Biochem Biophys Res Commun 2005; 337: 586-94.
16. McCartney-Francis NL, Chan J, Wahl SM. Inflammatory joint disease: clinical, histological, and molecular parameters of acute and chronic inflammation and tissue destruction. In: Winyard PG, Willoughby DA, editors. Inflammation Protocols. New Jersey: Humana Press, 2003: 147-59.
17. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-81.
18. Wilder RL. Hormones and autoimmunity: animal models of arthritis. Baillieres Clin Rheumatol 1996; 10: 259-71.
19. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989; 86: 2374-8.
20. Joe B, Cannon GW, Griffiths MM, Dobbins DE, Gulko PS, Wilder RL et al. Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocogenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis susceptibility loci. Arthritis Rheum 2002; 46: 1075-85.
21. Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol 1960; 85: 403-17.
22. van Noort JM, Anderton SM, Wagenaar JP, Wauben MH, van Holten C, Boog CJ. Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int Immunol 1994; 6: 603-9.
23. Gaston JS, Life PF, Jenner PJ, Colston MJ, Bacon PA. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med 1990; 171: 831-41.
24. Chang YH, Pearson CM, Chedid L. Adjuvant polyarthritis V: Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. J Exp Med 1981; 153: 1021-6.
25. Newbould BB. Role of lymph nodes in adjuvant-induced arthritis in rats. Ann Rheum Dis 1964; 23: 392-6.
26. Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Haines GK et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum 2000; 43: 1266-77.
27. Lussier A, De Médicis R, Tétreault L. Adjuvant arthritis: influence of the adjuvant volume and composition on the established arthritis. Int J Tissue React 1984; 6: 105-10.
28. Stanescu R, Lider O, van Eden W, Holoshitz J, Cohen IR. Histopathology of arthritis induced in rats by active immunization or by systemic transfer of T lymphocyte lines: a light and electron microscopic study of the articular surface using cationized ferritin. Arthritis Rheum 1987; 30: 779-92.
29. Feldmann M, Brennan FM, Maini RN. Role of cykokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
30. Szekanecz Z, Koch AE, Kunkel SL, Strieter RM. Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention. Drugs Aging 1998; 12: 377-90.
31. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35: 729-35.
32. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000; 51: 207-29.
33. Philippe L, Gegout-Pottie P, Guingamp C, Bordji K, Terlain B, Netter P et al. Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 1997; 273: R1550-6.
34. Silva JC, Rocha MF, Lima AA, Brito GA, de Menezes DB, Rao VS. Effect of pentoxifylline and nabumetone on the serum levels of IL-1β and TNF in rats with adjuvant arthritis. Inflamm Res 2000; 49: 14-9.